Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Clinical Laserthermia Systems

4.57 SEK

-1.72 %

Less than 1K followers

CLS B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Clinical Laserthermia Systems

2019202020212022202320242025
Revenue1.41.32.26.38.318.817.5
growth-%-6.6 %68.5 %179.3 %31.9 %127.1 %-6.9 %
EBITDA-39.7-47.5-57.9-65.0-63.2-51.6-
EBIT-42.4-50.5-60.7-67.4-65.9-54.3-28.8
Profit before taxes-42.3-56.2-64.1-71.3-80.9-47.9-42.0
Net income-42.3-56.2-64.1-71.3-80.9-47.6-42.0
EPS-57.48-60.16-71.01-53.21-23.12-4.30-1.60
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-2,782.5 %-3,567.6 %-2,578.6 %-1,036.5 %-764.6 %-274.7 %
EBIT-%-2,970.5 %-3,794.4 %-2,702.8 %-1,075.6 %-797.2 %-288.9 %-164.7 %
ROE-526.1 %-359.9 %-302.8 %-905.6 %-185.8 %-72.5 %-63.2 %
ROI-109.5 %-126.6 %-96.1 %-144.0 %-140.1 %-60.6 %-55.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.